LD-2 disclosure · 3rd Quarter - Amendment
ROCK & ASSOCIATES
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Lobbying and government relations.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM
Budget/Appropriations
Appropriations to fund the FDA implementation of compounding pharmacy regulations: H.R. 1625, Consolidated Appropriations Act 2018
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM
Pharmacy
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
LobbyistsSTEVE SYMMS · ROMANO ROMANI · mr THADDEUS E STROM